Department of Neurology West China Hospital Sichuan University Chengdu China.
Center of Cerebrovascular Diseases West China Hospital Sichuan University Chengdu China.
Brain Behav. 2017 Apr 21;7(6):e00697. doi: 10.1002/brb3.697. eCollection 2017 Jun.
To explore the association, if any, between the relationship between cardiac troponin and cerebral herniation after intracerebral hemorrhage (ICH).
Six hundred and eighty-seven consecutive ICH patients admitted to West China Hospital from May 1, 2014 to September 1, 2015 were retrospectively reviewed. Data on demographics, etiology, laboratory examinations at admission including serum cardiac troponin, computed tomography (CT) scans at admission and follow-up, and clinical outcomes were obtained. Using multiple logistic regression to identify the relationship of troponin and herniation. The association between troponin and hematoma volume was assessed using bivariate correlation and linear regression.
Among 188 (27.4%) patients who underwent the test of serum cardiac troponin at admission, 16 (8.5%) demonstrated cerebral herniation. The median time from symptom onset to CT at admission and follow-up was 4 and 30.25 hr, respectively. In multivariate analysis, elevated troponin was independently associated with cerebral herniation (adjusted odds ratio [OR] 5.19; 95% confidence interval [CI], 1.08-24.93). And those with elevated troponin had larger hematoma volume at follow-up in bivariate correlation (correlation coefficient, .375, = .003) and linear regression (β, .370, 95% CI, 0.062-0.320, = .005), higher National Institutes of Health Stroke Scale score (adjusted OR 2.06; 95% CI, 1.06-4.01, = .033) and lower Glasgow Coma Scale score (adjusted OR 2.34; 95% CI, 1.17-4.68, = .016) than those without.
Elevated cardiac troponin was associated with an almost five-fold increased risk of cerebral herniation, but not in-hospital mortality. The possibility of cerebral herniation should be considered when ICH patients with large hematoma volume and elevated troponin.
探讨脑心通胶囊对急性脑梗死患者神经功能及日常生活能力的影响。
选择 2016 年 1 月至 2018 年 1 月我院收治的急性脑梗死患者 106 例,随机分为观察组和对照组,每组 53 例。对照组给予常规西医治疗,观察组在对照组治疗基础上给予脑心通胶囊治疗。比较两组患者的临床疗效、神经功能缺损评分、日常生活能力评分、血液流变学指标、颈动脉粥样硬化斑块积分及不良反应发生情况。
观察组患者的临床疗效优于对照组(P<0.05)。治疗后,两组患者的神经功能缺损评分均明显降低,日常生活能力评分均明显升高,且观察组的变化幅度大于对照组(P<0.05)。治疗后,两组患者的全血高切黏度、全血低切黏度、血浆黏度、红细胞比容均明显降低,纤维蛋白原水平明显升高,且观察组的变化幅度大于对照组(P<0.05)。治疗后,两组患者的颈动脉内膜中层厚度、颈动脉粥样硬化斑块积分均明显降低,且观察组的变化幅度大于对照组(P<0.05)。两组患者的不良反应总发生率比较差异无统计学意义(P>0.05)。
脑心通胶囊治疗急性脑梗死患者的疗效确切,可明显改善患者的神经功能和日常生活能力,降低血液流变学指标,减轻颈动脉粥样硬化,且安全性较好。